Ashley Soet is a researcher who is passionate about harnessing cutting-edge molecular techniques to improve treatment outcomes for hepatocellular carcinoma in Australia and worldwide.

Supervised by Prof Ian Small, Ashley completed a Bachelor of Philosophy Honours in Biochemistry and Molecular Biology at the University of Western Australia in 2019.

Commencing in 2021, Ashley has been working as a UWA PhD candidate supervised by Dr Louise Winteringham, Prof Alistair Forrest, Dr Elena Denisenko and Dr Michael Wallace. He is studying the tumour microenvironment of hepatocellular carcinoma (HCC) using transcriptomics. The aim of this research is to uncover novel mechanisms for tumour drug resistance, immune evasion, and metastasis and additionally, to understand the role of tumour DNA mutational burden in these clinically relevant disease processes.

As of 2025, Ashley is performing spatial transcriptomics experiments and analysing single cell transcriptomics data derived from HCC human tissue samples which were made available through the Perkins Cancer Biobank.

Working at the Perkins as a member of the Liver Cancer Collaborative, Ashley believes that the study of tumour biology with high-resolution multi-omics technologies will be necessary to support the future of personalised medicine as an accessible means to defeat cancer.